Cargando…
Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist
Mas-related G protein-coupled receptor-X2 (MRGPRX2) expressed on mast cells (MCs) contributes to hypersensitivity reactions to cationic US-Food and Drug Administration (FDA) approved drugs such as the neuromuscular blocking agent, rocuronium. In addition, activation of MRGPRX2 by the neuropeptide su...
Autores principales: | Bawazir, Maram, Amponnawarat, Aetas, Hui, Yvonne, Oskeritzian, Carole A., Ali, Hydar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582160/ https://www.ncbi.nlm.nih.gov/pubmed/36275683 http://dx.doi.org/10.3389/fimmu.2022.1033794 |
Ejemplares similares
-
Murepavadin, a Small Molecule Host Defense Peptide Mimetic, Activates Mast Cells via MRGPRX2 and MrgprB2
por: Amponnawarat, Aetas, et al.
Publicado: (2021) -
GRK2 inhibitors, paroxetine and CCG258747, attenuate IgE-mediated anaphylaxis but activate mast cells via MRGPRX2 and MRGPRB2
por: Thapaliya, Monica, et al.
Publicado: (2022) -
MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants
por: Chompunud Na Ayudhya, Chalatip, et al.
Publicado: (2021) -
GRK2 differentially regulates FcεRI and MRGPRB2-mediated responses in mast cells
por: Thapaliya, Monica, et al.
Publicado: (2023) -
Analysis of TRPV channel activation by stimulation of FCεRI and MRGPR receptors in mouse peritoneal mast cells
por: Solís-López, A., et al.
Publicado: (2017)